tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market

ImmunityBio (IBRX) Cash flow

Compare
1,693 Followers

ImmunityBio Cash Flow

IBRX's free cash flow for Q3 2025 was $-68.91M. For the 2025 fiscal year, IBRX's free cash flow was decreased by $-783.00K and operating cash flow was $-68.91M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -391.24M$ -366.76M$ -337.51M$ -274.42M$ -171.72M
Investing Cash Flow
$ -12.25M$ -30.47M$ 27.30M$ -84.89M$ -19.81M
Financing Cash Flow
$ 281.63M$ 558.34M$ 233.61M$ 505.44M$ 150.68M
End Cash Position
$ 143.91M$ 265.79M$ 104.97M$ 181.28M$ 35.09M
Free Cash Flow
$ -398.12M$ -397.34M$ -415.67M$ -307.98M$ -173.39M
Currency in USD

ImmunityBio Cash Flow